Inflammation and oxidative damage in Alzheimer's disease: Friend or foe?

Frontiers in Bioscience - Scholar

Volumn 3 S, Issue 1, 2011, Pages 252-266

  Galimberti, Daniela ^a   Scarpini, Elio ^a  

^a UNIVERSITY OF MILAN   (Italy)

Author keywords

Alzheimer's disease; Amyloid beta; Inflammation; Nitric oxide; Oxidative damage; Review; Tau

Indexed keywords

ACUTE PHASE PROTEIN; ALPHA 1 ANTICHYMOTRYPSIN; AMYLOID PRECURSOR PROTEIN; APOLIPOPROTEIN E; APOLIPOPROTEIN E4; CELECOXIB; CHEMOKINE RECEPTOR CCR2; CHEMOKINE RECEPTOR CCR5; DAPSONE; DICLOFENAC; ENDOTHELIAL NITRIC OXIDE SYNTHASE; GAMMA INTERFERON INDUCIBLE PROTEIN 10; HYDROXYCHLOROQUINE; INDOMETACIN; INTERLEUKIN 1; INTERLEUKIN 11; INTERLEUKIN 1ALPHA; INTERLEUKIN 1BETA; INTERLEUKIN 6; INTERLEUKIN 8; MONOCYTE CHEMOTACTIC PROTEIN 1; MONOCYTE CHEMOTACTIC PROTEIN 2; NAPROXEN; NEURONAL NITRIC OXIDE SYNTHASE; NIMESULIDE; PROGRANULIN; RANTES; ROFECOXIB; ROSIGLITAZONE; TAU PROTEIN; ANTIINFLAMMATORY AGENT; CHEMOKINE; CYTOKINE; GRN PROTEIN, HUMAN; SIGNAL PEPTIDE;

ALLELE; ALZHEIMER DISEASE; ARTICLE; CEREBROVASCULAR ACCIDENT; GASTROINTESTINAL TOXICITY; GENE LINKAGE DISEQUILIBRIUM; GENE LOCUS; GENE MUTATION; GENETIC ASSOCIATION; GENETIC RISK; GENETIC VARIABILITY; HEART INFARCTION; HUMAN; INNATE IMMUNITY; MULTIGENE FAMILY; NERVOUS SYSTEM INFLAMMATION; OXIDATIVE STRESS; PATHOGENESIS; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; REGULATORY MECHANISM; SINGLE NUCLEOTIDE POLYMORPHISM; UPREGULATION; GENETICS; IMMUNOLOGY; INFLAMMATION; METABOLISM; PATHOPHYSIOLOGY; PHYSIOLOGY; REVIEW; RISK FACTOR;

ALZHEIMER DISEASE; AMYLOID BETA-PROTEIN PRECURSOR; ANTI-INFLAMMATORY AGENTS; APOLIPOPROTEINS E; CHEMOKINES; CYTOKINES; HUMANS; IMMUNITY, INNATE; INFLAMMATION; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; OXIDATIVE STRESS; RISK FACTORS; TAU PROTEINS;

EID: 79953297907     PISSN: 19450516     EISSN: 19450524     Source Type: Journal    
DOI: 10.2741/s149     Document Type: Article

References (137)

1. W.S. Griffin: Inflammation and neurodegenerative diseases. Am J Clin Nutr 3 (suppl), 470S-474S (2009) (Pubitemid 44713221)
2. M. Rak, M.R. Del Bigio, S. Mai, D. Westaway, K. Gough: Dense-core and diffuse Abeta plaques in TgCRND8 mice studied with synchrotron FTIR microspectroscopy. Biopolymers 87 (4), 207-217 (2007) (Pubitemid 350075351)
3. J.J.M.Hoozemans, R. Veerhuis, J.M. Rozemuller, P. Eikelenboom: Neuroinflammation and regeneration in the early stages of Alzheimer' s disease pathology. Int J Neuroscience 24, 157-165 (2006) (Pubitemid 43294622)
4. J. Hardy: Amyloid, the presenilins and Alzheimer's disease. Trends Neurosci 20 (4), 154-159 (1997) (Pubitemid 27116286)
5. R. Vassar: BACE1: the beta-secretase enzyme in Alzheimer's disease. J Mol Neurosci 23 (1- 2), 105-114 (2004)
6. T.M Allinson,. E.T Parkin,. A.J. Turner, N.M. Hooper: ADAMs family members as amyloid precursor protein alphasecretases. J Neurosci Res 74 (3), 342-352 (2003) (Pubitemid 37362810)
7. D. Edbauer, E. Winkler, J.T. Regula, B. Pesold, H. Steiner; C. Haass: Reconstitution of gamma-secretase activity. Nat Cell Biol 5 (5), 486-488 (2003)
8. EH Koo, R. Kopan: Potential role of presenilinregulated signaling pathways in sporadic neurodegeneration. Nat Med 10 Suppl, S26-33 (2004) (Pubitemid 38901864)
9. E. Storey, T. Spurck, J. Pickett-Heaps, K. Beyre uther, C.L. Masters: The amyloid precursor protein of Alzheimer's disease is found on the surface of static but not activity motile portions of neurites. Brain Res 735 (1), 59-66 (1996) (Pubitemid 26336620)
10. T. Yamazaki, E.H. Koo, D.J. Selkoe: Cell surface amyloid beta-protein precursor colocalizes with beta 1 integrins at substrate contact sites in neural cells. J Neurosci 17 (3), 1004-1010 (1997) (Pubitemid 27043959)
11. A. Ho, T.C. Südhof: Binding of F-spondin to amyloidbeta precursor protein: a candidate amyloid-beta precursor protein ligand that modulates amyloid-beta precursor protein cleavage. Proc Natl Acad Sci USA 101 (8) , 2548-5253 (2004)
12. H. Zheng, M. Jiang, M.E. Trumbauer, D.J. Sirinathsinghji, R. Hopkins, D.W. Smith, R.P. Heavens, G.R. Dawson, S. Boyce, M.W. Conner, K.A. Stevens, H.H. Slunt, S.S. Sisodia, H.Y. Chen, L.H. Van der Ploeg: beta- Amyloid precursor protein-deficient mice show reactive gliosis and decreased locomotor activity. Cell 81 (4), 525-531 (1995)
13. J. Herms, B. Anliker, S. Heber, S. Ring, M. Fuhrmann, H. Kretzschmar, S. Sisodia, U. Müller: Cortical dysplasia resembling human type 2 lissencephaly in mice lacking all three APP family members. EMBO J 23 (20), 4106-4115 (2004) (Pubitemid 39472431)
14. M. Leyssen, D. Ayaz, S.S. Hébert, S. Reeve, B. De Strooper, B.A. Hassan: Amyloid precursor protein promotes post-developmental neurite arborization in the Drosophila brain. EMBO J 24 (16), 2944-2955 (2005) (Pubitemid 43079897)
15. K. Yoshikawa, T. Aizawa, Y Hayashi: Degeneration in vitro of post-mitotic neurons overexpressing the Alzheimer amyloid protein precursor. Nature 359 (6390), 64-67 (1992)
16. G.B. Stokin, C. Lillo, T.L. Falzone, R.G. Brusch, E. Rockenstein, S,L. Mount, R. Raman, P. Davies, E. Masliah, D.S. Williams, L.S. Goldstein: Axonopathy and transport deficits early in the pathogenesis of Alzheimer's disease. Science 307 (5713), 1282-1288 (2005) (Pubitemid 40299973)
17. J. Hardy, D.J. Selkoe: The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics. Science 297 (5580), 353-356 (2002) (Pubitemid 34790756)
18. R.J. Castellani, A. Nunomura, H. Lee, G. Perry, M.A. Smith: Phosphorylated tau: toxic, protective, or none of the above. J. Alzh eimers Dis, 14, 377-383 (2008)
19. H. Akiyama, S. Barger, S. Barnum, B. Bradt, J. Bauer, G.M. Cole, N.R. Cooper, P. Eikelenboom, M. Emmerling, B.L. Fiebich, C.E. Finch, S. F rautschy, W.S.; Griffin, H. Hampel, M. Hull, G. Landreth, L. Lue, R. Mrak, I.R. Mackenzie, P.L. McGeer, M.K. O'Banion, J. Pachter, G. Pasinetti, C. Plata-Salaman, J. Rogers, R. Rydel, Y. Shen, W. Streit, R. Strohmeyer, I. Tooyoma, F.L. Van Muiswinkel, R. Veerhuis, D. Walker, S. Webster, B. Wegrzyniak, G. Wenk, T Wyss-Coray: Inflammation and Alzheimer' s disease. Neurobiol Aging, 21, 383-421 (2000)
20. K. Yaffe, K. Lindquist, B.W. Penninx, E.M. Simonsick, M. Pahor, S. Kritchevsky, L. Launer, L. Kuller, S. Rubin, T. Harris: Inflammatory markers and cognition in wellfunctioning A frican-American and white elders. Neurology 61 (1), 76-80 (2003) (Pubitemid 36818750)
21. M.J. Engelhart, M.I. Geerlings, J. Meijer, A. Kiliaan, A. Ruitenberg, J.C. van Swieten, T. Stijnen, A. Hofman, J.C. Witteman, M.M. Breteler:Inflammatory proteins in plasma and the risk of dementia : the Rotterdam study. Arch Neurol, 61, 668-672 (2004) (Pubitemid 38637682)
22. MG Dik, C. Jonker, C.E. Hack, J.H. Smit, H.C. Comijs, P. Eikelenboom: Serum inflammatory proteins and cognitive decline in older persons. Neurology 64, 1371-1377 (2005) (Pubitemid 40570504)
23. P.L. McGeer, M. Schulzer, E.G. Mc Geer: Arthritis and antiinflammatory agents as possible protective factors for Alzheimer' s disease: a review of 17 epidemiologic studies. Neurology 47, 425-432 (1996) (Pubitemid 26324038)
24. R. Veerhuis, M.J. Van Breemen, J.M.; Hoozemans, M. Morbin, J. Ouladhadj, F. Tagliavini, P. Eikelenboom: Amyloid beta plaque-associated proteins C1q and SAP enhance the Abeta 1-42 peptide-induced cytokine secret ion by adult human microglia in vitro. Acta Neuropathol 105, 135-144 (2003) (Pubitemid 36798799)
25. L. Meda, M.A. Cassatella, G.I. Szendrei, L. Otvos Jr.; P. Baron, M. Villalba, D. Ferrari, F. Rossi:A ctivation of microglial cells by beta-amyloid protein and interferongamma. Nature 374, 647-650 (1995)
26. E. Tarkowski, A. Wallin, K. Blennow, A. Tarkowski: Intracerebral production of tumor necr osis factor-alpha, a local neuroprotective agent, in Alzheimer disease and vascular dementia. J Clin Immunol 19, 223-230 (1999) (Pubitemid 29409451)
27. S.W. Barger, D. Hörster, K. Furukawa, Y. Goodman, J. Kriegl stein, M.P. Mattson: Tumor necrosis factors alpha and beta protect neurons against amyloid beta-peptide toxicity: evidence for involvement of a kappa B-binding factor and attenuation of peroxide and Ca2+ accumulation. Proc Natl Acad Sci USA 92, 9328-9332 (1995)
28. P. He, Z. Zhong, K. Lindholm, L. Berning, W. Lee, C. Lemere, M. Staufenbiel, R. Li, Y. Shen: Deletion of tumor necrosis factor death receptor inhibits amylo id b generation and prevents learning and memory deficits in Alzheimer's mice. J Cell Biol 178 (5), 829-841 (2007). (Pubitemid 47347367)
29. M. Cacquevel, N. Lebeurrier, S. Chéenne, D. Vivien: Cytokines in neuroinflammation and Alzheimer's disease. Current Drug Targets 5, 529-534 (2004) (Pubitemid 39004427)
30. S.A. Loddick, A.V. Turnbull, N.J. Rothwell: Cerebral interleukin-6 is neuroprotective during permanent focal ce rebral ischemia in the rat. J Cereb Blood Flow Metab 18: 176-179 (1998). (Pubitemid 28082514)
31. T. Taga, T. Kishimoto: Gp130 and the interleukin-6 family of cytokines. Annu Rev Immunol 15, 797-819 (1997) (Pubitemid 27169299)
32. D. Galimberti, E. Venturelli, C. Fenoglio, I. Guidi, C. Villa, L. Bergamaschini, F. Cortini, D. Scalabrini, P. Baron, C. Vergani, N. Bresolin, E. Scarpini: Intrathecal levels of IL-6, IL-11 and LIF in Alzheimer's disease and Frontotemporal Lobar Degeneration. J Neurol 255 (4), 539-544 (2008)
33. D. Galimberti, N. Schoonenboom, P. Scheltens, C. Fenoglio, F. Bouwman, E. Venturelli, I. Guidi, M.A. Blankenstein, N. Bresolin, E. Scarpini: Intrathecal chemokine synthesis in mild cognitive impairment and Alzheimer disease. Arch Neurol 63 (4), 538-543 (2006)
34. S. Lesnè, F. Docagne, C. Gabriel, G. Liot, D.K. Lahiri, L. Buèe, L. Plawinski, A. Delacourte, E.T. MacKenzie, A. Buisson, D. Vivien:Transforming growth factor-β1 potentiates amyloid-β generation in astrocytes and in transgenic mice. J Biol Chem 278 (20), 18408-18418 (2003) (Pubitemid 36799463)
35. J.M. Rozemuller, F.L. van Muiswinkel: Microglia and neurodegeneration. Eur J Clin Invest 30, 469-470 (2000)
36. W.J. Streit: Microglia as neuroprotective, immunocompetent cells of the CNS. Glia 40, 133-139 (2002) (Pubitemid 35337371)
37. E. Scarpini, D. Galimberti, P. Bar on, R. Clerici, M. Ronzoni, G. Conti, G. Scarlato: IP-10 and MCP-1 levels in CSF and serum from multiple sclerosis patients with different clinical subtypes of the disease. J Neurol Sci 195, 41-46 (2002) (Pubitemid 34175097)
38. M.Q. Xia, B.T. Hyman: Chemokines/chemokine receptors in the central nervous system and Alzheimer's disease. J Neurovirol 5, 32-41 (1999) (Pubitemid 29051876)
39. M.Q. Xia, S.X. Qin, L.J. Wu, C.R. Mackay, B.T. Hyman: Immunohistochemical study of the beta-chemokine receptors CCR3 and CCR5 and their ligands in normal and Alzheimer's disease brains. Am J Pathol 153, 31-37 (1998) (Pubitemid 28317504)
40. M.Q. Xia, B.J. Bacskai, R.B. Knowles, S.X. Qin, B.T. Hyman: Expression of the chemokine receptor CXCR3 on neurons and the elevated expression of its ligand IP-10 in reactive astrocytes: in vitro ERK1/2 activation and role in Alzheimer's disease. J Neuroimmunol 108, 227-235 (2000) (Pubitemid 30438772)
41. D. Galimberti, C. Fenoglio, C. Lovati, E. Venturelli, I. Guidi, B. Corrà, D. Scalabrini, F. Clerici, C. Mariani, N. Bresolin, E. Scarpini: Serum MCP-1 levels are increased in mild cognitive impairment and mild Alzheimer's disease. Neurobiol Aging 27 (12), 1763-1768 (2006) (Pubitemid 44572579)
42. D. Galimberti, E. Venturelli, C. Fenoglio, C. Lovati, I. Guidi, D. Scalabrini, C. Mariani, N. Bresolin, E. Scarpini: IP- 10 serum levels are not increased in Mild Cognitive Impairment and Alzheimer' s disease. Eur J Neurol 14 (4), e3-e4 (2007) (Pubitemid 46481147)
43. X. Zhu, A.K. Raina, H.G. Lee, G.M. Casadesus, M.A. Smith, G. Perry: Oxidative stress signaling in Alzheimer's disease. Brain Res 1000, 32-39 (2004) (Pubitemid 38446487)
44. W.R. Markesbery, J.M. Carney: Oxidative alterations in Alzheimer's disease. Brain Pathol 9, 133-146 (1999) (Pubitemid 29056524)
45. Y. Christen: Oxidative stress and Alzheimer's disease. Am J Clin Nutr 71, 621S-629S (2000)
46. G.E. Gibson, F.K. Sheu, J.P. Blass: Abnormalities of mitochondrial enzymes in Alzheimer's disease. J Neural Transm 105, 855-870 (1998) (Pubitemid 28539834)
47. I. Maurer, S. Zierz, H.J. Moller: A selective defect of cytochrome c oxidase is present in brain of Alzheimer's disease patients. Neurobiol Aging 21, 455-462 (2000) (Pubitemid 30349116)
48. D.A. Cottrell, E.L. Blakely, M.A. Johnson, P.G. I nce, D.M. Turnbull: Mitochondrial enzyme-deficient hippocampal neurons and choroidal cells in AD. Neurology 57, 260-264 (2001) (Pubitemid 32667359)
49. M.Y. Aksenov, H.M. Tucker, P. Nair, M.V. Aksenova, D.A. Butterfield, S. Estus, W.R. Markesbery: The expression of key oxidative stress-handling genes in different brain regions in Alzheimer's disease. J Mol Neurosci 11, 151-164 (1998) (Pubitemid 29140165)
50. M.G. Repetto, C.G. Reides, P. Evelson, S. Kohan, E.S. de Lustig, S.F. Llesuy: Peripheral markers of oxidative stress in probable Alzheimer's patients. Eur J Clin Invest 29, 643-649 (1999) (Pubitemid 29322378)
51. S. Seshadri, A. Beiserm, J Selhub, P.F. Jacques, I.H. Rosenberg, R.B. D'Agostino, P.W. Wilson, P.A. Wolf: Plasma homocysteine as a risk factor for dementia and Alzheimer 's disease. New Engl J Med 346, 476-483 (2002) (Pubitemid 34441738)
52. I.I. Kruman,T.S. Kumaravel, A. Lohani, W.A. Pedersen, R.G. Cutler, Y. Kruman, N. Haughey, J. Lee, M. Evans,M.P. Mattson: Folic acid deficiency and homocysteine impair DNA repair in hippocampal neurons and s ensitize them to amyloid toxicity in experimental models of Alzheimer's disease. J Neurosci 22, 1752-1762 (2002) (Pubitemid 35386293)
53. E.L. Streck, P.S. Vieira, C.M. Wannmacher, C.S. Dutra-Filho, M. Wajner, A.T. Wyse: In vitro effect of homocysteine on some parameters of oxidative stress in rat hippocampus. Metab Brain Dis 18, 147-154 (2003) (Pubitemid 36718127)
54. I. Guidi, D. Galimberti, E. Venturelli, C. Lovati, R. Del Bo, C. Fenoglio, A. Gatti, R. Dominici, S. Galbiati, R. Virgilio, S. Pomati, G.P. Comi, C. Mariani, G. Forloni, N. Bresolin, E. Scarpini: Influence of the Glu298Asp polymorphism of NOS3 on age at onset and homocysteine levels in AD patients. Neurobiol Aging 26 (6), 789-794 (2005) (Pubitemid 40249480)
55. A. Nunomura, G. Perry, G. Aliev, K. Hirai, A. Takeda, E.K. Balraj, P.K. Jones, H. Ghanbari, T. Wa taya, S. Shimohama, S. Chiba, C.S. Atwood, R.B. Petersen, M.A. Smith: Oxidative damage is the earliest event in Alzheimer disease. J Neuropathol Exp Neurol 60 (8), 759-767 (2001) (Pubitemid 32678256)
56. P. Rinaldi, M.C. Polidori, A. Metastasio, E. Mariani, P. Mattioli, A. Cherubini, M. Catani, R. Cecchetti, U. Senin, P. Mecocci: Plasma antioxidants are similarly depleted in mild cognitive impairment and in Alzhei mer's disease. Neurobiol Aging 24, 915-919 (2003) (Pubitemid 36962976)
57. D. Praticò, C.M. Clark, F. Liun, J. Rokach, V.Y. Lee, J.Q. Trojanowski: Increase of brain oxidative stress in mild cognitive impairment: a possible predictor of Alzheimer 's disease. Arch Neurol 59, 972-976, (2002) (Pubitemid 34640757)
58. D. Praticò, S. Sung: Lipid peroxidation and oxidative imbalance: early functional events in Alzheimer's disease. J Alzheimers Dis 6, 171-175 (2004) (Pubitemid 38560253)
59. I. Guidi, D. Galimbe rti, S. Lonati, C. Novembrino, F. Bamonti, M. Tiriticco, C. Fenoglio, E. Venturelli, P. Baron, N. Bresolin, E. Scarpini: Oxidative imbalance in patients with mild cognitive impairment and Alzheimer's disease. Neurobiol Aging 27, 262-269 (2006) (Pubitemid 43038550)
60. K. Tahara, H. Kim, J. Jin, J.A. Maxwell, L. Li, K. Fukuchi: Role of toll-like receptor signalling in Aβ uptake and clearance. Brain 129, 3006-3019 (2006) (Pubitemid 44684521)
61. P. Minoretti, C. Gazzaruso, C.D. Vito, M. Bianchi, E. Coen, M. Reino, D. Geroldi: Effect of the functional toll-like receptor 4 Asp299Gly polymorphism on susceptibility to la teonset alzheimer's disease. Neurosci Lett 391 (3), 147-149 (2006) (Pubitemid 41736189)
62. C.R. Balistreri, M.P. Grimaldi, M. Chiappelli, F. Licastro, L. Castiglia, F. Listi, S. Vasto, D. Lio, C. Caruso, G. Candore: Association between the polymorphism of TLR4 and CD14 genes and Alzheimer's disease. Curr Pharm Des 14 (26), 2672-2677 (2008)
63. E. Emanuele, A. D'Angelo, C. Tomaino, G. Binetti, R. Ghidoni, P. Politi, L. Bernardi, R. Maletta, A.C. Bruni, D. Geroldi: Circulating levels of soluble receptor for advanced glycation end products in Alzheimer disease and vascular dementia. Arch Neurol 62 (11), 1734-1736 (2005) (Pubitemid 41626671)
64. R. Ghidoni, L. Benussi, M. Glionna, M. Franzoni, D. Geroldi, E. Emanuela, G. Binetti: Decreased plasma levels of soluble receptor for advanced glycation end products in mild cognitive impairment. J Neural Transm 115 (7), 1047-1050 (2008)
65. L. Yao, K. Li, L. Zhang, S. Yao, Z. Piao, L. Song: Influence of the Pro12Ala polymprphism of PPAR-gamma on age at onset and sRAGE levels in Alzheimer' s disease. Brain Res 1291 , 133-139 (2009)
66. L. Bertram, R.E. Tanzi: The genetic epidemiology of neurodegenerative disease. J Clin Invest 115 (6): 1449-1157 (2005)
67. J.M. Kwon, A.M. Goate: The candidate gene approach. Alcohol Res Health 24 (3):164-168 (2000).
68. E.H. Corder, A.M. Saunders, W.J. Strittmatter, D.E. Schmechel, P.C. Gaskell, G.W. Small, A.D. Roses, J.L.Haines, M.A. Pericak-Vance: Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families. Science 261 (5123), 921-923 (1993) (Pubitemid 23275809)
69. M.A. Pericak-Vance, J.L. Bebout, P.C. Gaskell Jr, L.H. Yamaoka, W.Y. Hung, M.J. Alberts, A.P. Walker, R.J. Bartlett, C.A. Haynes, K.A. Wel sh, et al: Linkage studies in familial Alzheimer disease: evidence for chromosome 19 linkage. Am J Hum Genet 48 (6), 1034-1050 (1991) (Pubitemid 21903065)
70. J. Raber, Y.Huang Y J.W. Ashford: ApoE genotype accounts for the vast majority of AD risk and AD pathology. Neurobiol Aging 25 (5), 641-650 (2004). (Pubitemid 38686487)
71. M. Poli, L.B. Gatta, C. Lovati, C. Mariani, D. Galimberti, E. Scarpini, I. Biunno, M. Musicco, R. Dominici, A. Albertini, D. Finazzi: Interaction between the APOE varepsilon4 allele and the APH-1b c+651T>G SNP in Alzheimer's disease. Neurobiol Aging 29 (10), 1494-1501 (2008)
72. L.A. Farrer, C.R. Abraham, L. Volicer, E.J. Foley, N.W. Kowall, A.C. McKee, J.M. Wells: Allele epsilon 4 of apolipoprotein E shows a dose effect on age at onset of Pick disease. Exp Neurol 136, 162-170 (1995). (Pubitemid 3015685)
73. L. Gustafson, M. Abrahamson, A. Grubb, K. Nilsson, G. Fex: Apolipoprotein-E genotyping in Alzheimer's disease and frontotemporal dementia. Dement Geriatr Cogn Disord 8, 240-243 (1997). (Pubitemid 27243709)
74. S. Helisalmi, K. Linnaranta, M. Lehtovirta, A. Mannermaa, O. Heinonen, M. Ryynänen, P. Riekkinen Sr, H. Soininen: Apolipoprotein E polymorphism in patients with different neurod egenerative disorders. Neurosci Lett 205, 61-64 (1996). (Pubitemid 26062227)
75. M. Stevens, C.M. van Duijn, P. de Knijff, C. van Broeckhoven, P. Heutink, B.A. Oostra, M.F. Niermeijer, J.C. van Swieten: Apolipoprotein E gene and sporadic frontal lobe dementia. Neurology 48, 1526-1529 (1997).
76. S.F. Fabre, C. Forsell, M. Viitanen, M. Sjögren, A. Wallin, K. Blennow, M. Blomberg, C. Andersen, L.O. Wahlund, L. Lannfelt: Clinic-based cases with frontotemporal dementia show increased cerebrospinal fluid tau and high apolipoprotein E epsilon4 frequency, but no tau gene mutations. Exp Neurol 168, 413-41 8 (2001). (Pubitemid 32289777)
77. L. Bernardi, R.G. Maletta, C. Tomaino, N. Smirne, M. Di Natale, M. Perri, T. Longo, R. Colao, S.A. Curcio, G. Puccio, M. Mirabelli, T. Kawarai, E. Rogaeva, P.H. St George Hyslop, G. Passarino, G. De Benedictis, A.C. Bruni: The effects of APOE and tau gene variability on risk of frontotemporal dementia. Neurobiol Aging 27 (5), 702-709 (2006).
78. D. Ges chwind, J. Karrim, S.F. Nelson, B. Miller B: The apolipoprotein E epsilon4 allele is not a significant risk factor for frontotemporal dementia. Ann Neurol 44, 134-138 (1998). (Pubitemid 28323665)
79. R.A. Short, N.R. Graff-Radford, J. Adamson, M. Baker, M. Hutton M: Differences in tau and apolipoprotein E polymorphism frequencies in sporadic frontotemporal lobar degeneration syndromes. Arch Neurol 59, 611-615 (2002). (Pubitemid 34289965)
80. M. Riemenschneider, J. Diehl, U. Muller, H. Forstl, A. Kurz: Apolipoprotein E polymorphism in German patients with frontotemporal degeneration. J Neurol Neurosurg Psych 72, 639-641 (2002). (Pubitemid 34462820)
81. R. Srinivasan, Y. Davidson, L. Gibbons, A. Payton, A.M. Richardson, A. Varma, C. Julien, C. Stopford, J. Thompson, M.A. Horan, N. Pendleton, S.M. Pickering-Brown, D. Neary, J.S. Sno wden, D.M. Mann: The apolipoprotein E epsilon4 allele selectively increases the risk of frontotemporal lobar degeneration in males. J Neurol Neurosurg Psych 77, 154-158 (2006). (Pubitemid 43220833)
82. Y. Du, R.C. Dodel, B.J. Eastwood,K.R. Bales, F. Gao, F. Lohmüller, U. Müller, A. Kurz, R. Zimmer, R.M. Evans, A. Hake, T. Gasser, W.H. Oertel, W.S. Griffin, S.M. Paul, M.R. Farlow: Association of an interle ukin 1 alpha polymorphism with Alzheimer's disease. Neurology 55 (4), 480-483 (2000). (Pubitemid 30648897)
83. L.M. Grimaldi, V.M. Casadei, C. Ferri, F. Veglia, F. Licastro, G. Annoni, I. Biunno, G. De Bellis, S. Sorbi, C. Mariani, N. Canal, W.S. Griffin, M. Franceschi: Association of early-onset alzheimer's disease with an interleukin-1alpha gene polymorphism. Ann Neurol 47 (3), 361-365 (2000). (Pubitemid 30141846)
84. J.A. Nicoll, R.E. Mrak, D.I. Graham, J. Stewart, G. Wilcock, S. MacGowan, M.M. Esiri, L.S. Murray, D. Dewar, S. Love, T. Moss, W.S. Griffin: Association of interleukin-1 gene polymorphis ms with Alzheimer's disease. Ann Neurol 47 (3), 365-368 (2000). (Pubitemid 30141847)
85. A. Papassotiropoulos, M. Bagli, F. Jessen, T.A. Bayer, W. Maier, M.L. Rao, R. Heun: A genetic variation of the inflammatory cytokine interleukin-6 delays the initial onset and reduces the risk for sporadic Alzheimer's disease. Ann Neurol 45 (5), 666-668 (1999). (Pubitemid 29217598)
86. F. Licastro, M. Chiappelli M: Brain immune responses cognitive decline and dementia: relationship with phenotype expression and genetic background. Mech Ageing Dev 124, 539-548 (2003). (Pubitemid 36514911)
87. J.S. Collins, R.T. Perry, B. Watson Jr, L.E. Harrell, R.T. Acton, D. Blacker, M.S. Albert, R.E. Tanzi, S.S. Bassett, M.G. McInnis, R.D. Campbell, R.C. Go: Association of a haplotype for tumor necrosis factor in siblings with late-onset alzheimer disease: the NIMH Alzheime r Disease Genetics Initiative. Am J Med Genet 96 (6), 823-830 (2000).
88. D. Blacker, M.A. Wilcox, N.M. Laird, L. Rodes, S.M. Horvath, R.C. Go, R. Perry, B. Watson Jr, S.S. Bas sett , M.G. McInnis, M.S. Albert, B.T. Hyman, R.E. Tanzi: Alpha-2 macroglobulin is genetically associated with Alzheimer disease. Nat Genet 19 (4), 357-360 (1998). (Pubitemid 28357907)
89. C. Huerta, V. Alvarez, I.F. Mata, E. Coto, R. Ribacoba, C. Martínez, M. Blázquez, L.M. Guisasola, C. Salvador, C.H. Lahoz, J. Peña: Chemokines (RANTES and MCP-1) and chemokine-receptors (CCR2 and CCR5) gene p olymorphisms in Alzheimer's and Parkinson's disease. Neurosci Lett 370 (2-3), 151-154 (2004). (Pubitemid 39377738)
90. O. Combarros, J. Infante, J. Llorca, J Berciano: No evidence for association of the mon ocyte chemoattractant protein-1 (-2518) gene polymorphism and Alzheimer's disease. Neurosci Lett 360 (1-2), 25-28 (2004). (Pubitemid 38471979)
91. C. Fenoglio, D. Galimberti, C. Lovati, I. Guidi, A. Gatti, S. Fogliarino, M. Tiriticco, C. Mariani, G. Forloni, C. Pettenati, P. Baron, G. Conti, N. Bresolin, E. Scarpini: MCP-1 in Alzheimer's disease patients: A-2518G polymorphism and serum levels. Neurobiol Aging 25 (9), 1169-1173 (2004). (Pubitemid 39094019)
92. D. Galimberti, C. Fenoglio, C. Lovati, A. Gatti, I. Guidi, E. Venturelli, G.R. Cutter, C. Mariani, G. Forloni, C. Pettenati, P. Baron, G. Con ti, N. Bresolin, E. Scarpini: CCR2-64I polymorphism and CCR5Delta32 deletion in patients with Alzheimer's disease. J Neurol Sci 225 (1- 2), 79-83 (2004). (Pubitemid 39311713)
93. O. Combarros, J. Infante, J. Llorca, N. Pena N, C. Fernandez-Viadero, J. Berciano: The chemokine receptor CCR5-Delta32 gene mutation is not protective against Alzheimer's disease. Neurosci Lett 366 (3), 312-314 (2004). (Pubitemid 39024288)
94. C. Villa, E. Venturelli, C. Fenoglio, F. Clerici, A. Marcone, L. Benussi, R. Ghidoni, S. Gallone, F. Cortini, D. Scalabrini, M. Serpente, G. Binetti, S. Cappa, C. Mariani, I. Rain ero, N. Bresolin, E. Scarpini, D. Galimberti: CCL8/MCP-2 association analysis in patients with Alzheimer's disease and frontotemporal lobar degeneration. J Neurol 256 (8), 1379-1381 (2009)
95. E. Venturelli, D. Galimberti, C. Fenoglio, C. Lovati, D. Finazzi, I. Guidi, B. Corrà, D. Scalabrini, F. Clerici, C. Mariani, G. Forloni, N. Bresolin, E. Scarpini: Candidate gene analysis of IP- 10 gene in patients with Alzheimer's disease. Neurosci Lett 404 (1-2), 217-221 (2006). (Pubitemid 44041805)
96. E. Venturelli, D. Galimberti, C. Lovati, C. Fenoglio, D. Scalabrini, C. Mariani, G. Forloni, N. Bresolin, E. Scarpini: The T-786C NOS3 polymorphism in Alzheimer's disease: association and influence on gene expression. Neurosci Lett 382 (3), 300-303 (2005). (Pubitemid 40733640)
97. M. Dahiyat, A. Cumming, C. Harrington, C. Wischik, J. Xuereb, F. Corrigan, G. Breen, D. Shaw, D. St Clair: A ssociation between Alzheimer's disease and the NOS3 gene. Ann Neurol 46 (4), 664-667 (1999). (Pubitemid 29466449)
98. F. Crawford, M. Freeman, L. Abdullah, J. Schinka, M. Gold, R. Duara, M. Mullan: No association betwe en the NOS3 codon 298 polymorphism and Alzheimer's disease in a sample from the United States. Ann Neurol 47 (5), 687 (2000) (Pubitemid 30261915)
99. M. Sanchez-Guerra, O. Combarros, A. Alvarez-Arcaya, I. Mateo, J. Bercian o, J. Gonzalez-Garcia, J Llorca: The Glu298Asp polymorphism in the NOS3 gene is not associated with sporadic Alzheimer's disease. J Neurol Neurosurg Psych 70, 566-567 (2001) (Pubitemid 32269708)
100. A. Tedde, B. Nacmias, E. Cellini, S. Bagnoli, S Sorbi: Lack of association between NOS3 polymorphism and Italian sporadic and familial Alzheimer' s disease. J Neurol 249, 110-111 (2002) (Pubitemid 34126396)
101. R. Monastero, A.B. Cefalù, C. Camarda, C.M. Buglino, M. Mannino, C.M.Barbagallo, G. Lopez, L.K. Camarda, S. Travali, R. Camarda, M.R. Averna: No association between Glu298Asp endothelial nitric oxide synthase polymorphism an d Italian sporadic Alzheimer's disease. Neurosci Lett 341, 229-232 (2003) (Pubitemid 36403770)
102. I. Guidi, D. Galimberti, E. Venturelli, C. Lovati, R. Del Bo, C. Fenoglio, A. Gatti, R. Dominici, S. G albiati, R. Virgilio, S. Pomati, G.P. Comi, C. Mariani, G. Forloni, N. Bresolin, E. Scarpini: Influence of the Glu298Asp polymorphism of NOS3 on age at onset and homocysteine levels in AD patients. Neurobiol Aging 26 (6), 789-794 (2005) (Pubitemid 40249480)
103. K.S. Brown, L.A. Kluijtmans, I.S. Young, J. Woodside, J.W. Yarnell, D. McMaster, L. Murray, A.E. Evans, C.A. Boreham, H. McNulty, J.J. Strain, L.E. Mitchell, A.S. Whitehead: Genetic evidence that nitric oxide modulates homocysteine: the NOS3 894TT genotype is a risk factor for hyperhomocystenemia. Arterioscler Thromb Vasc Biol 23 (6), 1014-1020 (2003) (Pubitemid 36713554)
104. D. Galimberti, E. Venturelli, A. Gatti, C. Lovati, C. Fenoglio, C. Mariani, G. Forloni, N. Bresolin, E. Scarpini: Association of neuronal nitric oxide synthase C276T polymorphism with Alzheimer's disease. J Neurol 252, 985-986 (2005) (Pubitemid 41186974)
105. Y.J. Liou, C.J. Hong, H.C. Liu, C.Y. Liu, T.Y. Liu, I.C. Chen, S.J. Tsai: No association between the neuronal nitric oxide synthase gene polymorphism and Alzheimer' s disease. Am J Med Gen 114, 687-688 (2002)
106. D. Galimberti, E. Scarpini, E. Venturelli, A Strobel, S. Herterich, C. Fenoglio, I. Guidi, D. Scalabrini, F. Cort ini, N. Bresolin, K.P. Lesch, A. Reif: Association of a NOS1 promoter repeat with Alzheimer's disease. Neurobiol Aging 29 (9), 1359-1365 (2008) (Pubitemid 351970600)
107. Y. Wang, D.C. Newton, G.B. Robb, C.L. Kau, T.L. Miller, A.H. Cheung, A.V. Hall, S. VanDamme, J.N. Wilcox, P.A. Marsden: RNA diversity has profound effects on the translation of neuronal nitric oxide synthase. Proc Natl Acad Sci USA 96 (21), 12150-12155 (1999) (Pubitemid 29502873)
108. D. Saur, J.M. Vanderwinden, B. Seidler, R.M. Schmid, M.H. De Laet, H.D. Allescher: Single-nucleotide promoter polymorphism alters transcription of neuronal nitric oxide synthase exon 1c in infantile hypertroph ic pyloric stenosis. Proc Natl Acad Sci USA 101 (6), 1662-1667 (2004) (Pubitemid 38234211)
109. A. Reif, S. Herterich, A. Strobel, A.C. Ehlis, D. Saur, C.P. Jacob, T. Wienker, T. Töpner, S. Fr itzen, U. Walter, A. Schmitt, A.J. Fallgatter, K.P. Lesch: A neuronal nitric oxide synthase (NOS-I) haplotype associated with schizophrenia modifies prefrontal cortex function. Mol Psych 11 (3), 286-300 (2006)
110. M. Baker, I.R. Mackenzie, S.M. Pickering-Brown, J. Gass, R. Rademakers, C. Lindholm, J. Snowden, J. Adamson, A.D. Sadovnick, S. Rollinson, A. Cannon, E. Dwosh, D. Neary, S. Me lquist, A. Richardson, D. Dickson, Z. Berger, J. Eriksen, T. Robinson, C. Zehr, C.A. Dickey, R. Crook, E. McGowan, D. Mann, B. Boeve, H. Feldman, M. Hutton: Mutations in progranulin cause tau-negati ve frontotemporal dementia linked to chromosome 17. Nature 442, 916-919 (2006) (Pubitemid 44285946)
111. M. Cruts, I. Gijselinck, J. van der Zee,S. Engelborghs, H. Wils, D. Pirici, R. Rademakers, R. Vandenbergh e, B. Dermaut, J.J. Martin, C. van Duijn, K. Peeters, R. Sciot, P. Santens, T. De Pooter, M. Mattheijssens, M. Van den Broeck, I. Cuijt, K. Vennekens, P.P. De Deyn, S. Kumar-Singh, C. Van Broeckhoven : Null mutations in progranulin cause ubiquitinpositive frontotemporal dementia linked to chromosome 17q21. Nature 442, 920-924 (2006) (Pubitemid 44285947)
112. J. Zhu, C. Nathan, W. Jin, D. Sim, G.S. Ashcroft, S.M. Wahl, L. Lacomis, H. Erdjument-Bromage, P. Tempst , C.D. Wright, A. Ding A: Conversion of proepithelin to epithelins: roles of SLPI and elastase in host defense and wound repair. Cell 111, 867-878 (2002) (Pubitemid 36106407)
113. Z. Ahmed, I.R. Mackenzie, M.L. Hutton, D.W. Dickson: Progranulin in frontotemporal lobar degeneration and neuroinflammation. J Neuroinflammation 4, 7 (2007)
114. R. D aniel, Z. He, K.P. Carmichael, J. Halper, A. Bateman: Cellular localization of gene expression for progranulin. J Histochem Cytochem 48, 999-1009 (2000) (Pubitemid 30421564)
115. G. Coppola, A. Karydas, R. Rademakers, Q. Wang, M. Baker, M. Hutton, B.L. Miller, D.H. Geschwind: Gene expression study on peripheral blood identifies progranulin mutations. Ann Neurol 64, 92-96 (2008)
116. N. Brouwers, K. N uytemans, J. van der Zee, I. Gijselinck, S. Engelborghs, J. Theuns, S. Kumar-Singh, B.A. Pickut, P. Pals, B. Dermaut, V. Bogaerts, T. De Pooter, S. Serneels, M. Van den Broeck, I. Cuijt, M. Mattheijs s ens, K. Peeters, R. Sciot, J.J. Martin, P. Cras, P. Santens, R. Vandenberghe, P.P. De Deyn, M. Cruts, C. Van Broeckhoven, K. Sleegers: Alzheimer and Parkinson diagnoses in progranulin null mutation carriers in an extended founder family. Arch Neurol 64, 1436-1446 (2007) (Pubitemid 47572667)
117. L. Benussi, R. Ghidoni, E. Pegoiani, D.V. Moretti, O. Zanetti, G. Binetti: Progranulin Leu271LeufsX10 is one of the most c ommon FTLD and CBS associated mutation worldwide. Neurobiol Dis 33, 379-385 (2009)
118. M. Carecchio, C. Fenoglio, M. De Riz, I. Guidi, C. Comi, F. Cortini, E. Venturelli, I. Restelli, C. Cantoni, N. Bresolin, F. Monaco, E. Scarpini, D. Galimberti D: Progranulin plasma levels as potential biomarker for the identification of GRN deletion carriers. A case with atypical onset as clinical amnestic Mild Cognitive Im pairment converted to Alzheimer's disease. J Neurol Sci 15, 291-293 (2009).
119. N. Brouwers, K. Sleegers, S. Engelborghs, S. Maurer-Stroh, I. Gijselinck, J. van der Zee, B.A. Pickut, M. Van den Broeck, M. Mattheijssens, K. Peeters, J. Schymkowitz, F. Rousseau, J.J. Martin, M. Cruts, P.P. De Deyn, C. Van Broeckhoven: Genetic variability in progranulin contributes to risk for clinically diagnosed Alz heimer disease. Neurology 71, 656-664 (2008)
120. C. Fenoglio , D. Galimberti, F. Cortini, J.S. Kauwe, C. Cruchaga, E. Venturelli, C. Villa, M. Serpente, D. Scalabrini, K. Mayo, L.M. Piccio, F. Clerici, D. Albani, C. Mariani, G. Forloni, N. Bresolin, A.M. Goate, E. Scarpini: rs5848 variant influences GRN mRNA levels in brain and peripheral mononuclear cells in patients with Alzheimer's diseas e. J Alzheimers Dis 18 (3), 603-612 (2009)
121. D. Galimberti, C. Fenoglio, F. Cortini, M. Serpente, E. Venturelli, C. Villa, F. Clerici, A. Marcone, L. Benussi, R. Ghidoni , S. Gallone, D. Scalabrini, I. Restelli, F. Martinelli Boneschi, S. Cappa, G. Binetti, C. Mariani, I. Rainero, M.T. Giordana, N. Bresolin, E. Scarpini: GRN Variability Contributes to Sporadic Frontotempora l Lobar Degeneration. J Alzheimers Dis 19 (1), 171-177 (2010)
122. A. Grupe, Y. Li, C. Rowland, P. Nowotny, A.L. Hinrichs, S. Smemo, J.S. Kauwe, T.J. Maxwell, S. Cherny, L. Doil, K. Tacey, R. van Luchene, A. Myers, F. Wavrant-De Vrièze, M. Kaleem, P. Hollingworth, L. Jehu, C. Foy, N. Archer, G. Hamilton, P. Holmans, C.M. Morris, J. Catanese, J. Sninsky, T.J. White, J. Powell, J. Hardy, M. O'Donovan, S. Lovestone, L. Jones, J. C. Morris,
123. Y. Li, A. Grupe, C. Rowland, P. Nowotny, J.S. Kauwe, S. Smemo, A. Hinrichs, K. Tacey, T.A. Toombs, S. Kwok, J. Catanese, T.J. White, T.J. Maxwell, P- Hollingworth, R. Abraham, D.C. Rubinsztein, C. Brayne, F. Wavrant-De Vrièze, J. Hardy, M. O'Donovan, S. Lovestone, J.C. Morris, L.J. Thal, M. Owen, J. Williams, A. Goate: DAPK1 variants are associated with Alzheimer's disease and allele-specific expression. Hum Mol Genet 15 (17), 2560-2568 (2006) (Pubitemid 44288686)
124. D. Harold, R. Abraham, P. Hollingworth, R. Sims, A. Gerrish, M.L. Hamshere, J.S. Pahwa, V. Moskvina, K. D owzell, A. Williams, N. Jones, C. Thomas, A. Stretton, A.R. Morgan, S. Lovestone, J. Powell, P. Proitsi, M.K. Lupton, C. Brayne, D.C. Rubinsztein, M. Gill, B. Lawlor, A. Lynch, K. Morgan, K.S. Brown, P.A. Passmore, D. Craig, B. McGuinness, S. Todd, C. Holmes, D. Mann, A.D. Smith, S. Love, P.G. Kehoe, J. Hardy, S. Mead, N. Fox, M. Rossor, J. Collinge, W. Maier, F. Jessen, B. Sc h ürmann, H. van den Bussche, I. Heuser, J. Kornhuber, J. Wiltfang, M. Dichgans, L. Frölich, H. Hampel, M. Hüll, D. Rujescu, A.M. Goate, J.S. Kauwe, C. Cruchaga, P. Nowotny, J.C. Morris, K. Mayo, K. Sleegers, K. Bettens, S. Engelborghs, P.P. De Deyn, C. Van Broeckhoven, G. Livingston, N.J. Bass, H. Gurling, A. McQuillin, R. Gwilliam, P. Deloukas, A. Al-Chalabi, C.E. Shaw, M. Tsol a ki, A.B. Singleton, R. Guerreiro, T.W. Mühleisen, M.M. Nöthen, S. Moebus, K.H. Jöckel, N. Klopp, H.E. Wichmann, M.M. Carrasquillo, V.S. Pankratz, S.G. Younkin, P.A. Holmans, M. O'Donovan, M.J. Owen, J. Williams: Genome-wide association study identifies variants at CLU and PICALM associated with Alzheimer's disease. Nat Genet 41 (10), 1088-1093 (2009)
125. J.C. Lambert, S. Heat h, G. Even, D. Campion, K. Sleegers, M. Hiltunen, O. Combarros, D. Zelenika, M.J. Bullido, B. Tavernier, L. Letenneur, K. Bettens, C. Berr, F. Pasquier, N. Fiévet, P. Barberger-Gateau, S. E ngelborghs, P. De Deyn, I. Mateo, A Franck, S. Helisalmi, E. Porcellini, O. Hanon, European Alzheimer's Disease Initiative Investigators, M.M. de Pancorbo, C. Lendon, C. Dufouil, C. Jaillard, T. Leveillard, V. Alvare z , P. Bosco, M. Mancuso, F. Panza, B. Nacmias, P. Bossù, P. Piccardi, G. Annoni, D. Seripa, D. Galimberti, D. Hannequin, F. Licastro, H. Soininen, K. Ritchie, H. Blanché, J.F. Dartigues, C. Tzourio, I. Gut, C. Van Broeckhoven, A. Alpér ovitch, M. Lathrop, P- Amouyel: Genome-wide association study identifies variants at CLU and CR1 associated with Alzheimer's disease. Nat Genet 41 (10), 1094-1099 (2009)
126. C.A. Szekely, J.E. Thorne, P.P. Zandi, M. Ek, E. Messias, J.C. Breitner, S.N. Goodman: Nonsteroidal antiinflammatory drugs for the prevention of Alzheimer' s disease: a systematic review. Neuroepidemiology, 23, 159-169 (2004) (Pubitemid 38980441)
127. S.A. Reines, G.A. Block, J.C. Morris, G. Liu, M.L. Nessly, C.R. Lines, B.A. Norman, C.C. Baranak, Rofecoxib Protocol 091 Study Group: Rofecoxib: no effect on Alzheimer 's disease in a 1-year, randomized, blinded, controlled study. Neurology 62, 66-71 (2004)
128. P.S. Aisen, K.A. Schafer, M. Grundman, E. Pfeiffer, M. Sano, K.L. Davis, M.R. Farlow, S. Jin, R.G. Thomas, L.J. Thal, Alzheimer' s Disease Cooperative Study: Effects of rofecoxib or naproxen vs placebo on Alzheimer's disease progression: a randomized controlled trial. JAMA 289, 2819-2826 (2003) (Pubitemid 37430117)
129. S. Scharf, A. Mander, A. Ugoni, F. Vajda, N.A. Christophidis: double-blind, placebo controlled trial of diclofenac/misoprostol in Alzheimer' s disease. Neurology 53, 197-201 (1999) (Pubitemid 29329671)
130. H. Soininen, C. West, J. Robbins, L. Niculescu: Long-term efficacy and safety of celecoxib in Alzheimer' s disease. Dement Geriatr Cogn Disord 23 (1), 8-21 (2007) (Pubitemid 46005786)
131. J.L. Eriksen, S.A. Sagi, T.E. Smith, S. Weggen, P. Da s, D.C. McLendon, V.V. Ozols, K.W. Jessing, K.H. Zavitz, E.H. Koo, T.E. Golde: NSAIDs and enantiomers of flurbiprofen target gamma-secretase and lowe Abeta 42 in vivo. J Clin Invest 112 (3), 440-449 ( 2003) (Pubitemid 38063773)
132. P.S. Aisen, D.B. Marin, A.M. Brickman, J. Santoro, M. Fusco: Pilot tolerability studies of hydroxychloroquine and colchicine in Alzheimer disease. Alz Dis Assoc Disord 15 (2), 96-1 01 (2001) (Pubitemid 32525448)
133. P.S. Aisen, J. Schmeidler, G.M. Pasinetti: Randomized pilot study of nimesulide treatment in Alzheimer's disease. Neurology 58 (7), 1050-1054 (2002) (Pubitemid 34298544)
134. J. Rogers, L.C. Kirby, S.R. Hempelman, D.L. Berry, P.L. McGeer, A.W. Kaszniak, J. Zalinski, M. Cofield, L. Mansukhani, P. Willson, et al: Clinical trial of indomethacin in Alzheimer' s disease. Neurology 43, 1609-1611 (1993) (Pubitemid 23230557)
135. N. Tabet, H. Feldman: Indomethacin for the treatment of Alzheimer's disease patients. Cochrane Database Syst Rev CD003673 (2002)
136. M.E. Risner, A.M. Saunders, J.F. Altman, G.C. Ormandy, S. Craft, I.M. Foley, M.E. Zvartau-Hind, D.A. Hosford, A.D. Roses: Rosiglitazone in Alzheimer's Disease Study Group. Efficacy of rosiglitazone in a genetically defined population with mild-to-moderate Alzheimer's disease. Pharmacogenomics J 6 (4), 246-254 (2006) (Pubitemid 44137951)
137. B. Dubois, H.H. Feldman, C. Jacova, S.T. Dekosky, P. Barberger-Gateau, J. Cummings, A. Delacourte, D. Galasko, S. Gauthier, G. Jicha, K. Meguro, J. O'brien, F. Pasquier, P. Robert, M. Rosso r, S. Salloway, Y. Stern, P.J. Visser, P. Scheltens: Research criteria for the diagnosis of Alzheimer's disease: revising the NINCDS-ADRDA criteria. Lancet Neurol 6 (8), 734-746 (2007) (Pubitemid 47058377)